We are delighted to announce that Telma Lança has joined our Business Development team.
Telma has a long track record with pre-clinical and clinical immunology and a solid foundation within T cell biology. Her background and deep knowledge in the fields of immuno-oncology and target discovery will strengthen Immunitrack’s ambition of becoming a world leader within T cell immunogenicity prediction and assessment.
Before joining Immunitrack, Telma worked as Senior R&D Scientist at Unikum Therapeutics, Copenhagen, following postdoc positions at the laboratories of Professor William Agace at the Technical University of Denmark and Professor Ton Schumacher at Leiden University, Netherlands. Telma is a great team player and we welcome her to the Immunitrack family.